FindTrial
Sign In

Using Proseal laryngeal mask airway is beneficial for anaesthesia in obese patients

ProSeal TM LMA increases safe apnea period in morbidly obese patients:a single blind randomised prospective study - ProSeal TM LMA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/05/002679
Enrollment
80
Registered
2012-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Morbidly obese patients Age 18 or more

Interventions

Intervention1: ProSeal (a supra glottic device)with face mack and oropharyngeal tube: The effect of ventilation using these device with face mack and oropharyngeal tube on the safe apnea time Control

Sponsors

Max super Speciality Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of age 18-60 years 2. BMI >35 kg/m2 3. Posted for elective surgery

Exclusion criteria

Exclusion criteria: 1. Patients with mouth opening less than 2.5 cm 2. Any obvious difficult airway 3. one episode of gastro-esophageal reflux per week will be excluded 4. Pregnancy 5. Cardiac or pulmonary disease 6. SpO2 at ambient air 94% 7. Carotid stenosis

Design outcomes

Primary

MeasureTime frame
Safe apnea timeTimepoint: SpO2 92% diring apnic phase—

Secondary

MeasureTime frame
Recovery Time or the time taken to recover SpO2 to 98% pO2bl : pO2 baseline pO2 preox :pO2 at end of preoxygenation pO2 apnea : pO2 prior to commencement of ventilation pO2Hypox: pO2 at the time of reaching SpO2 92 % Timepoint: Baseline SpO2 92% during apnic phase Time to recover back to SpO2 100%—

Countries

India

Contacts

Public ContactAparna Sinha

Max Super Speciality Hospital

apsin@hotmail.com9810035503

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026